Person:
ELÇİOĞLU, ÖMER CELAL

Profile Picture
Status
Organizational Units
OrgUnit Logo
Organizational Unit
Job Title
First Name
ÖMER CELAL
Last Name
ELÇİOĞLU
Name
Email Address
Birth Date

Filters

2020 - 202440
Reset filters

Settings

Start date: 2020 × End date: 2024 ×

Search Results

Now showing 1 - 10 of 40
  • Thumbnail Image
    PublicationOpen Access
    Comparative Evaluation of Orthostatic Hypotension in Patients with Diabetic Nephropathy.
    (2021-07-20T00:00:00Z) Aytaş, Gamze; Elçioğlu, Ömer C; Kazancıoğlu, Rümeyza; Gürsu, Meltem; Artan, A Serra; Yabacı, Ayşegül; Soysal, PINAR; Bilgi, Kadir; Özçelik, Semra; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL; GÜRSU, MELTEM; YABACI TAK, AYŞEGÜL; SOYSAL, PINAR; ÖZÇELİK, SEMRA
    Introduction: Orthostatic hypotension (OH) affects 5-20% of the population. Our study investigates the presence of OH in diabetic nephropathy (DNP) patients and the factors affecting OH in comparison with nondiabetic chronic kidney disease (NDCKD) patients. Method: Patients presented to the nephrology clinic, and those who consented were included in the study. DNP was defined by kidney biopsy and/or clinical criteria. NDCKD patients of the same sex, age, and eGFR were matched to DNP patients. Demographic parameters and medications were obtained from the records. OH was determined by Mayo clinic criteria. The same researcher used an electronic device to measure blood pressure (BP). All samples were taken and analyzed the same day for biochemical and hematologic parameters and albuminuria. Results: 112 (51 F, 61 M, mean age: 62.56 ± 9.35 years) DNP and 94 (40 F, 54 M, mean age: 62.23 ± 10.08 years) NDCKD patients were included. There was no significant difference between DNP and NDCKD groups in terms of OH prevalence (70.5 vs. 61.7%, p = 0.181). Male patients had significantly higher OH prevalence than female patients (74.7 vs. 60.0%, p = 0.026). There was no significant difference in change in systolic BP between the groups (24.00 [10.00-32.00] mm Hg vs. 24.00 [13.75-30.25] mm Hg, p = 0.797), but the change in diastolic BP was significantly higher in the DNP group (8.00 [2.00-13.00] mm Hg vs. 6.00 [2.00-9.00] mm Hg, p = 0.025). In the DNP group, patients with OH had significantly higher uric acid levels than those without OH (7.18 ± 1.55 vs. 6.36 ± 1.65 mg/dL, p = 0.017). And, 73.7% of patients on calcium channel blockers developed OH (p = 0.015), and OH developed in 80.6% of 36 patients on alpha-blockers (p = 0.049). Conclusion: OH prevalence is very high in CKD, and etiology of CKD does not have a statistically significant effect on the frequency of OH, despite a difference that could be meaningful clinically. Therefore, patients with CKD are checked for OH, with or without concurrent diabetes mellitus. Evaluation of postural BP changes should be a part of nephrology practice.
  • No Thumbnail Available
    PublicationMetadata only
    Otozomal Dominant Polikistik Böbrek Hastalığında Total Oksidan/Antioksidan Seviyelerin Böbrek Fonksiyonlarıyla İlişkisi
    (2021-10-13T00:00:00Z) Aris, Özlem; Büyükaydın, Banu; Artan, Ayşe Serra; Mirioğlu, Şafak; Gürsu, Meltem; Kazancıoğlu, Rümeyza; Elçioğlu, Ömer Celal; MİRİOĞLU, ŞAFAK; GÜRSU, MELTEM; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL
  • No Thumbnail Available
    PublicationMetadata only
    Doğru Kan Basinci Ölçümü İçin İki Yöntemin Karşilaştirilmasi: Manuel Ölçüm Ve Otomatik Cihaz İle Ölçüm.
    (2021-10-13T00:00:00Z) KUŞDOĞAN, ENES; ARTAN, AYŞE SERRA; GÜRSU, MELTEM; MİRİOĞLU, ŞAFAK; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL
  • No Thumbnail Available
    PublicationMetadata only
    Otozomal Dominant Polikistik Böbrek Hastalarında Üriner Sistem Taşı Oluşumuna Eğilim Oluşturan Metabolik Faktörler
    (2021-10-13T00:00:00Z) Chasan, Onour; Artan, Ayşe Serra; Gürsu, Meltem; Mirioğlu, Şafak; Kazancıoğlu, Rümeyza; Elçioğlu, Ömer Celal; CHASAN, ONOUR; GÜRSU, MELTEM; MİRİOĞLU, ŞAFAK; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL
  • No Thumbnail Available
    PublicationMetadata only
    THE PREVALENCE, CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN TURKISH ADULTS: THE DATA FROM TSN-GOLD (TURKISH SOCIETY OF NEPHROLOGY GLOMERULAR DISEASES) WORKING GROUP
    (2020-06-01T00:00:00Z) KURULTAK, İLHAN; Gungor, Ozkan; Ozturk, Savas; Dirim, Ahmet Burak; EREN, NECMİ; Yenigun, Ezgi; Dal, Elbis Ahbap; DİNCER, Mevlüt Tamer; BORA, FEYZA; AKGÜR, SUAT; Sumnu, Abdullah; DURSUN, BELDA; SİPAHİ, SAVAŞ; Getinkaya, Hakki; ŞAHİN, İDRİS; ŞAHİN, GARİP; Yilmaz, Murvet; Vatansever, Bulent; AYDIN, EMRE; ULU, MEMNUNE SENA; Gundogan, Ali; UstOndag, Sedat; Sayarlioglu, Hayriye; Sahin, Gizem Kumru; ELÇİOĞLU, Ömer Celal; Aydin, Zeki; Selcyk, Nedim Yilmaz; ÖNAL, CEREN; Oruc, Meric; Kucuk, Mehmet; Aktas, Nimet; DERİCİ, ÜLVER; SÜLEYMANLAR, GÜLTEKİN; ELÇİOĞLU, ÖMER CELAL
  • No Thumbnail Available
    PublicationMetadata only
    Effects of keto-analogs in the pathologic findings of diabetic nephropatic rats
    (2020-01-01T00:00:00Z) Kazancıoğlu, Rümeyza; Çoban, Ganime; Gürsu, Meltem; Elçioğlu, Ömer Celal; Deligöz Bilkdacı, Yelda; ÇOBAN, GANİME; GÜRSU, MELTEM; ELÇİOĞLU, ÖMER CELAL
  • No Thumbnail Available
    PublicationMetadata only
    Kronik Böbrek Hastasında Covid-19 Enfeksiyonu Sonrası Gelişen Nefrotik Sendrom: Olgu Sunumu
    (2021-10-13T00:00:00Z) Abdulhayoğlu, Necat İrem; Gürsu, Meltem; Elçioğlu, Ömer Celal; Mirioğlu, Şafak; Kazancıoğlu, Rümeyza; ABDULHAYOĞLU, NECAT İREM; GÜRSU, MELTEM; ELÇİOĞLU, ÖMER CELAL; MİRİOĞLU, ŞAFAK
  • Thumbnail Image
    PublicationOpen Access
    COVİD-19 infection in a membranous nephropathy patient treated with rituximab.
    (2020-09-04T00:00:00Z) Elcioglu, Omer Celal; Artan, Ayse Serra; Mirioglu, Safak; Gursu, Meltem; Durdu, Bulent; Koc, Meliha Meric; Okyaltirik, Fatmanur; Gultekin, Mehmet Ali; Kazancioglu, Rümeyza; ELÇİOĞLU, ÖMER CELAL; MİRİOĞLU, ŞAFAK; GÜRSU, MELTEM; DURDU, BÜLENT; MERİÇ KOÇ, MELİHA; OKYALTIRIK, FATMANUR; GÜLTEKİN, MEHMET ALİ; KAZANCIOĞLU, RÜMEYZA
    While COVID-19 pandemic continues to afect our country and most countries in the world, we have to make some changes both in our social life and our approach to healthcare. We have to struggle with the pandemic on one hand and also try to follow up and treat our patients with chronic diseases in the most appropriate way. In this period, one of our group of patients who are challenging us for follow-up and treatment are those who should start or continue to use immunosuppressive therapy. In order to contribute to the accumulation of knowledge in this area, we wanted to report a patient who was followed up with the diagnosis of COVID-19 and had been administered rituximab very recently due to a nephrotic syndrome caused by membranous nephropathy.
  • No Thumbnail Available
    PublicationMetadata only
    Renal Biopsy in Patients with Diabetes: Indications, Results, and Clinical Predictors of Diabetic Kidney Disease
    (2021-02-01T00:00:00Z) Artan, Ayşe Serra; Kazancıoğlu, Rümeyza; Elçioğlu, Ömer Celal; Çoban, Ganime; Gürsu, Meltem; GÜRSU, MELTEM; ÇOBAN, GANİME; ELÇİOĞLU, ÖMER CELAL; KAZANCIOĞLU, RÜMEYZA
  • No Thumbnail Available
    PublicationMetadata only
    COVID-19 pandemisi sırasında periton diyalizi hastalarında teletıp kullanımı
    (2020-10-15T00:00:00Z) Gürsu, Meltem; Artan, Ayşe Serra; Elçioğlu, Ömer Celal; Mirioğlu, Şafak; Kazancıoğlu, Rümeyza; GÜRSU, MELTEM; ELÇİOĞLU, ÖMER CELAL; MİRİOĞLU, ŞAFAK; KAZANCIOĞLU, RÜMEYZA